NCT03924895 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 166
- group Id
- BG001
- value
- 259
- group Id
- BG002
- value
- 170
- group Id
- BG003
- value
- 595
- units
- Participants
- groups
- description
- Participants receive 3 preoperative cycles of pembrolizumab, followed by standard of care surgery, followed by 14 cycles of postoperative pembrolizumab. Each cycle is 21 days.
- id
- BG000
- title
- Arm A: Pembrolizumab + Surgery
- description
- Participants receive standard of care surgery alone.
- id
- BG001
- title
- Arm B: Surgery Alone
- description
- Participants receive 3 preoperative cycles of EV + pembrolizumab, followed by standard of care surgery, followed by 6 cycles of postoperative EV + pembrolizumab, followed by 8 cycles of pembrolizumab alone. Each cycle is 21 days.
- id
- BG002
- title
- Arm C: Enfortumab Vedotin (EV) + Pembrolizumab + Surgery
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.9
- value
- 71.8
- group Id
- BG001
- spread
- 7.7
- value
- 71.9
- group Id
- BG002
- spread
- 7.9
- value
- 72.1
- group Id
- BG003
- spread
- 7.8
- value
- 71.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 33
- group Id
- BG003
- value
- 135
- title
- Female
- measurements
- group Id
- BG000
- value
- 130
- group Id
- BG001
- value
- 193
- group Id
- BG002
- value
- 137
- group Id
- BG003
- value
- 460
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 26
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 155
- group Id
- BG001
- value
- 231
- group Id
- BG002
- value
- 160
- group Id
- BG003
- value
- 546
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 23
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 85
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 7
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 148
- group Id
- BG001
- value
- 205
- group Id
- BG002
- value
- 132
- group Id
- BG003
- value
- 485
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 11
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 6
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 163
- group Id
- BG001
- value
- 223
- group Id
- BG002
- value
- 142
- group Id
- BG003
- value
- 528
- title
- Cisplatin-Ineligible
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 28
- group Id
- BG003
- value
- 67
- title
- Cisplatin-Eligible but Declined
- description
- Particpants were categorized according to their cisplatin status: ineligible for cisplatin-based chemotherapy or eligible for but declined cisplatin-based chemotherapy
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Cisplatin Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 82
- title
- T2N0
- measurements
- group Id
- BG000
- value
- 150
- group Id
- BG001
- value
- 209
- group Id
- BG002
- value
- 133
- group Id
- BG003
- value
- 492
- title
- T3/T4aN0
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 21
- title
- T1-4aN1
- description
- Imaging of the chest, abdomen, and pelvis was performed within ≤28 days before randomization to assess tumor status as follows: T2N0: Stage II; tumor invades muscularis propria, no regional nodes, and generally has better outcomes. T3/T4aN0: Stage III; extends into perivesical tissue or adjacent organs, no regional nodes, and has worse outcomes. T1-4aN1: Stage III; tumor with one regional lymph node metastasis, generally associated with the worst outcomes. Disease staging was assessed centrally after review of the pathology and imaging results.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Tumor Clinical Stage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 73
- title
- United States (US)
- measurements
- group Id
- BG000
- value
- 73
- group Id
- BG001
- value
- 110
- group Id
- BG002
- value
- 78
- group Id
- BG003
- value
- 261
- title
- European Union (EU)
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 116
- group Id
- BG002
- value
- 71
- group Id
- BG003
- value
- 261
- title
- Most of World (MOW)
- description
- Participants were categorized according to their geographic region (United States, European Union, or Most of World)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Geographic Region
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 166
- group Id
- BG001
- value
- 259
- group Id
- BG002
- value
- 170
- group Id
- BG003
- value
- 595
- units
- Participants
- groups
- description
- Participants receive 3 preoperative cycles of pembrolizumab, followed by standard of care surgery, followed by 14 cycles of postoperative pembrolizumab. Each cycle is 21 days.
- id
- BG000
- title
- Arm A: Pembrolizumab + Surgery
- description
- Participants receive standard of care surgery alone.
- id
- BG001
- title
- Arm B: Surgery Alone
- description
- Participants receive 3 preoperative cycles of EV + pembrolizumab, followed by standard of care surgery, followed by 6 cycles of postoperative EV + pembrolizumab, followed by 8 cycles of pembrolizumab alone. Each cycle is 21 days.
- id
- BG002
- title
- Arm C: Enfortumab Vedotin (EV) + Pembrolizumab + Surgery
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.9
- value
- 71.8
- group Id
- BG001
- spread
- 7.7
- value
- 71.9
- group Id
- BG002
- spread
- 7.9
- value
- 72.1
- group Id
- BG003
- spread
- 7.8
- value
- 71.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 33
- group Id
- BG003
- value
- 135
- title
- Female
- measurements
- group Id
- BG000
- value
- 130
- group Id
- BG001
- value
- 193
- group Id
- BG002
- value
- 137
- group Id
- BG003
- value
- 460
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 26
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 155
- group Id
- BG001
- value
- 231
- group Id
- BG002
- value
- 160
- group Id
- BG003
- value
- 546
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 23
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 85
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 7
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 148
- group Id
- BG001
- value
- 205
- group Id
- BG002
- value
- 132
- group Id
- BG003
- value
- 485
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 11
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 6
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 163
- group Id
- BG001
- value
- 223
- group Id
- BG002
- value
- 142
- group Id
- BG003
- value
- 528
- title
- Cisplatin-Ineligible
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 28
- group Id
- BG003
- value
- 67
- title
- Cisplatin-Eligible but Declined
- description
- Particpants were categorized according to their cisplatin status: ineligible for cisplatin-based chemotherapy or eligible for but declined cisplatin-based chemotherapy
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Cisplatin Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 82
- title
- T2N0
- measurements
- group Id
- BG000
- value
- 150
- group Id
- BG001
- value
- 209
- group Id
- BG002
- value
- 133
- group Id
- BG003
- value
- 492
- title
- T3/T4aN0
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 21
- title
- T1-4aN1
- description
- Imaging of the chest, abdomen, and pelvis was performed within ≤28 days before randomization to assess tumor status as follows: T2N0: Stage II; tumor invades muscularis propria, no regional nodes, and generally has better outcomes. T3/T4aN0: Stage III; extends into perivesical tissue or adjacent organs, no regional nodes, and has worse outcomes. T1-4aN1: Stage III; tumor with one regional lymph node metastasis, generally associated with the worst outcomes. Disease staging was assessed centrally after review of the pathology and imaging results.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Tumor Clinical Stage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 73
- title
- United States (US)
- measurements
- group Id
- BG000
- value
- 73
- group Id
- BG001
- value
- 110
- group Id
- BG002
- value
- 78
- group Id
- BG003
- value
- 261
- title
- European Union (EU)
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 116
- group Id
- BG002
- value
- 71
- group Id
- BG003
- value
- 261
- title
- Most of World (MOW)
- description
- Participants were categorized according to their geographic region (United States, European Union, or Most of World)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Geographic Region
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle